Why Invest in Ludwig Enterprises
- The WHO estimates that 50% of the world’s deaths are a result of illnesses such as cancer, diabetes, COPD & heart disease that has chronic inflammation as a causation.
- The mRNA Inflammatory Index™ is a patent pending technology combined with AI that assesses the biomarkers of chronic inflammation.
- NuGenea™ is a scientifically formulated nutraceutical proven through extensive research to reduce chronic inflammation
Why Invest in Ludwig’s mRNA Technology?
- The mRNA market is $39.9 Billion
- It is growing at 1.7% per year
- Ludwig’s holds a unique position in this growing industry!
- The mRNA Inflammatory Index™ is an assay that measures mRNA levels in body
Investor
The World Health Organization estimates that 50% of deaths worldwide are caused by inflammation related chronic diseases such as Heart Disease, COPD, Diabetes and various cancers. Ludwig Enterprises, Inc.(OTC: LUDG) The Genomics Language Company™ and Dr. Marvin S. Hausman MD have created a one-of-a-kind technology that measures 48 different mRNA biomarkers, proven scientifically to be indicators of chronic inflammation. Combined with AI and deep machine learning the mRNA Inflammatory Index™ (patent pending) can have a significant potential positive impact on the health of the world’s population possible driving the prevention of chronic illnesses and potentially achieving early detection for certain cancers.
Results from initial assessments helped gain IRB approval for a clinical study for early detection of bladder cancer and it’s recurrence and shows promising results for the early detection of colon cancer.
Healthcare Professional Message
“Chronic Inflammatory Disease have been recognized as the most significant cause of death in the world today, with more than 50% of all deaths been attributable to inflammation-related diseases.” (https://www.ncbi.nlm.nih.gov/books/NBK493173/)
Ludwig Enterprises, Inc. The Genomics Language Company™ has developed new tools to be used the fight against chronic inflammation, including the mRNA Inflammatory Index™
The mRNA Inflammatory Index™, created by Dr. Marvin S. Hausman MD, assess 48 mRNA biomarkers such as the pro-inflammatory cytokines like IL-10, IL-1B and TNF-a. Combined with AI and deep machine learning Ludwig is creating a database that may help clinicians identify for their patients whether or not they are facing chronic inflammatory processes that may lead to chronic illness or cancer.